Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone and Fludrocortisone for CIRCI
NCT04404400Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2022
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone, fludrocortisone in critical illness-related corticosteroid insufficiency (CIRCI), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2022; status: recruiting.
02
Drugs
hydrocortisonefludrocortisone
03
Conditions
critical illness-related corticosteroid insufficiency (CIRCI)
Beyond the preview
Go deeper on NCT04404400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04404400.